Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]
Products Offered[1]The Co. manufactures male condoms, female condoms, water-based lubricant jelly, IVD products such as Pregnancy Test Kits, Covid 19 Antigen Test Kit, HIV Test Kit, Dengue test kits, Malaria antigen test kits, etc.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Godrej Consumer | 1226.90 | 66.69 | 125541.88 | 1.22 | 459.34 | -2.86 | 3825.09 | 4.33 | 19.21 | 14853.33 | 19.81 | 1882.61 | 481.14 | 10.32 | 9.93 | 0.34 |
| 2. | Dabur India | 513.75 | 50.37 | 91123.33 | 1.56 | 444.79 | 6.48 | 3191.32 | 5.37 | 20.24 | 12781.29 | 18.50 | 1808.97 | 452.55 | 8.32 | 11.06 | 0.12 |
| 3. | Colgate-Palmoliv | 2092.30 | 42.92 | 56907.55 | 2.44 | 327.51 | -17.10 | 1519.50 | -6.15 | 105.34 | 5877.91 | 31.82 | 1325.91 | 327.51 | 35.96 | 46.23 | 0.04 |
| 4. | P & G Hygiene | 12336.00 | 48.44 | 40043.56 | 0.89 | 209.86 | -0.96 | 1150.17 | 1.32 | 103.79 | 4326.46 | 26.15 | 826.61 | 209.86 | 43.00 | 32.72 | 0.00 |
| 5. | Gillette India | 8039.00 | 45.64 | 26199.10 | 1.39 | 143.65 | 8.00 | 810.81 | 3.71 | 56.06 | 2970.55 | 27.82 | 573.99 | 143.65 | 22.53 | 21.84 | 0.00 |
| 6. | Emami | 501.95 | 29.07 | 21910.12 | 1.59 | 148.35 | -30.24 | 798.51 | -10.34 | 32.42 | 3715.13 | 25.35 | 753.77 | 148.35 | 7.48 | 22.73 | 0.02 |
| 7. | Cupid | 464.85 | 202.17 | 12479.70 | 0.00 | 24.12 | 140.24 | 90.21 | 90.80 | 17.10 | 266.82 | 33.52 | 61.73 | 24.12 | 32.74 | 11.99 | 0.07 |
| – | Median: 14 Co. | 483.4 | 50.37 | 10922.74 | 0.14 | 42.29 | 6.48 | 526.69 | 5.37 | 19.21 | 1560.15 | 22.58 | 130.47 | 42.29 | 10.32 | 12.83 | 0.04 |
Standalone figures in ₹ crores
| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 46 | 43 | 42 | 35 | 36 | 40 | 66 | 44 | 47 | 51 | 61 | 65 | 90 |
Expenses | 33 | 29 | 31 | 32 | 29 | 28 | 32 | 32 | 31 | 35 | 43 | 43 | 56 |
Operating Profit | 13 | 14 | 11 | 3 | 7 | 12 | 34 | 12 | 16 | 16 | 18 | 21 | 34 |
Other Income | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 12 | 13 | 11 | 2 | 6 | 12 | 32 | 11 | 14 | 14 | 16 | 20 | 32 |
Tax % | 30% | 24% | 25% | 3% | 20% | 24% | 26% | 22% | 29% | 21% | 28% | 23% | 25% |
Net Profit | 9 | 10 | 8 | 2 | 5 | 9 | 24 | 8 | 10 | 11 | 12 | 15 | 24 |
EPS in Rs | 0.32 | 0.38 | 0.31 | 0.08 | 0.19 | 0.33 | 0.89 | 0.31 | 0.37 | 0.41 | 0.43 | 0.56 | 0.90 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 20 | 44 | 61 | 84 | 81 | 85 | 160 | 143 | 133 | 159 | 172 | 183 | 267 |
Expenses | 17 | 32 | 36 | 50 | 53 | 65 | 108 | 107 | 109 | 118 | 121 | 141 | 177 |
Operating Profit | 2 | 13 | 25 | 34 | 27 | 21 | 52 | 36 | 23 | 41 | 51 | 42 | 89 |
Other Income | 0 | 1 | 2 | 1 | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 19 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 3 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 5 |
Profit before tax | 0 | 11 | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 55 | 82 |
Net Profit | 0 | 8 | 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 41 | 62 |
EPS in Rs | 0.00 | 0.29 | 0.60 | 0.77 | 0.64 | 0.57 | 1.49 | 1.09 | 0.65 | 1.18 | 1.49 | 1.52 | 2.30 |
Dividend Payout % | 0% | 22% | 21% | 22% | 29% | 35% | 15% | 21% | 35% | 21% | 0% | 0% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 | 27 |
Reserves | 7 | 13 | 25 | 43 | 55 | 63 | 90 | 118 | 129 | 154 | 288 | 315 | 354 |
Borrowings | 3 | 2 | 1 | 0 | 2 | 2 | 31 | 0 | 9 | 6 | 12 | 19 | 27 |
Other Liabilities | 5 | 8 | 14 | 9 | 10 | 15 | 30 | 22 | 23 | 16 | 7 | 11 | 34 |
Total Liabilities | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 442 |
Fixed Assets | 16 | 16 | 16 | 16 | 16 | 21 | 26 | 29 | 31 | 36 | 58 | 67 | 67 |
Gross Block | 32.72 | 34.06 | 35.93 | 38.53 | 40.95 | 47.51 | 55.46 | 60.84 | 65.11 | 73.38 | 98.37 | 111.34 | – |
Accumulated Depreciation | 16.44 | 18.44 | 20.37 | 22.47 | 24.65 | 26.66 | 29.15 | 31.70 | 34.35 | 37.32 | 40.24 | 44.72 | – |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 6 | 0 | 0 | 6 | 9 |
Investments | 0 | 0 | 0 | 5 | 18 | 22 | 21 | 48 | 54 | 69 | 147 | 103 | 14 |
Other Assets | 10 | 19 | 35 | 42 | 44 | 50 | 114 | 74 | 84 | 83 | 114 | 196 | 353 |
Total Assets | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 442 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | -0 | 7 | 13 | 20 | 3 | 18 | 19 | 42 | 10 | 33 | 8 | -11 |
Cash from Investing Activity | -0 | -1 | -1 | -5 | -9 | -14 | -37 | -9 | -13 | -22 | -80 | 45 |
Cash from Financing Activity | 1 | -3 | -6 | -4 | -3 | -5 | 16 | -33 | 3 | -11 | 99 | -1 |
Net Cash Flow | 0 | 3 | 6 | 11 | -9 | -0 | -2 | 0 | -1 | -0 | 27 | 32 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 59 | 67 | 79 | 59 | 100 | 97 | 95 | 65 | 84 | 59 | 102 | 134 |
Inventory Days | 165 | 155 | 60 | 133 | 259 | 168 | 437 | 230 | 197 | 229 | 184 | 450 |
Days Payable | 81 | 84 | 27 | 80 | 162 | 135 | 579 | 168 | 134 | 105 | 1 | 13 |
Cash Conversion Cycle | 144 | 139 | 112 | 112 | 198 | 130 | -46 | 127 | 147 | 183 | 285 | 570 |
Working Capital Days | 59 | 58 | 77 | 67 | 130 | 108 | 40 | 87 | 87 | 77 | 123 | 210 |
ROCE % | 3% | 48% | 79% | 72% | 43% | 29% | 50% | 28% | 17% | 26% | 22% | 17% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
No credit ratings.
Aug 2025
May 2025
Aug 2024
Apr 2024
Jan 2024
Nov 2023
Aug 2023
Jun 2023
Feb 2023
Nov 2022
Aug 2022
Jun 2022
Feb 2022
Nov 2021
Aug 2021
Jun 2021
Feb 2021
Nov 2020
Sep 2020
Jan 2020
Nov 2019
Jul 2019
Jun 2019
Feb 2019
Nov 2018
Aug 2018
Feb 2018
Nov 2017
Jul 2017
May 2017
Nov 2016
Jul 2016
May 2016
Stock Analysis
Cupid Limited is an Indian manufacturer and exporter specializing in male and female condoms, personal lubricants, and In-Vitro Diagnostic (IVD) kits, serving both domestic and international markets.
Robust B2B export order book of $11.50 Million (₹100 Cr+) scheduled for execution in Q2/Q3 FY26. South African tender visibility of USD 12.98 million annually.
While not in the current news, historical data indicates increases in debtor and working capital days, suggesting potential areas for management attention.
Corporate Announcements